TP53 and neoplasm: In this study, we engineered several mouse tumor cell lines by introducing either p53 mutant (p53N236S, p53N239S in human) or/and Ras mutant (H-RasV12) into mouse embryo fibroblasts (MEFs) with p53−/− genetic background.